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Natural product inspired scaffolds for 
activity-based protein profiling   
 
 
Natural products are an amazing source of inspiration for the development of drugs 
and activity-based probes. Recently, impressive advances have been made in the field 
of activity-based probes and its applications leading to powerful tools. We discuss 
here the basis of activity-based protein profiling of natural products and the several 









1.1 Natural products in the ‘omics age  
 
There is recently an interesting inclination to revisit natural product inspired 
scaffolds for drug discovery and chemical proteomics.1-4 Historically, natural 
products were the main (or only) source of medicines, drugs and medicinal 
preparations and they are still the main source for recently approved 
medicines. However, for a while, other techniques like high-throughput 
screenings for specific targets and combinatorial chemistry were the central 
interest of pharmaceutical companies and research groups. Natural 
compounds were considered not compatible with these high-throughput 
methodologies, since their scaffolds are often challenging to synthesize, 
characterize or even to isolate. Sample preparation thus hampered the use of 
natural products in these campaigns and as a consequence natural products 
were disregarded as leads for several decades.   
Figure 1. Structure of natural products today on the market and their corresponding 
activities and origins. 
Despite the challenges in sample preparation, it is remarkable that natural 
products were ignored as leads, in particular, since the results of high-
throughput screenings were to some extend disappointing. Moreover 
secondary metabolites are sculpted to interact with biological targets, often 
display high bioavailability and have obtained great results reaching the 
market. An abundant number of secondary metabolites and their associated 













































these metabolites can be used to fine-tune biological responses.2 This 
reasoning, in combination with the failures in high-throughput screenings 
led to a renewed interest of the drug discovery field in natural product 
inspired scaffolds.   
 
Key step in designing drugs and chemical probes based on natural product 
scaffolds is the identification of scaffolds that have interesting biological 
properties (Figure 1). The identification of such scaffolds can be divided in 
two steps, a chemical and a biological step. The chemical identification is 
based on a thorough study of literature of the scaffold’s structure 
elucidation. The synthetic accessibility of the scaffold should then be 
evaluated together with the possible scaffold modifications for structure-
activity relationship (SAR) study or incorporation of tags. The scaffold 
should preferably be structurally different from known inhibitors and drugs 
to increase the chance of finding unprecedented targets and leads. As for the 
biological identification, phenotypic assays or protein-based assays are 
commonly used to assess the biological properties. Results from these 
experiments can help to gain information into the potential target, off targets 
or pathways leading to the observed activity.  The information collected 
from these two steps should help the design and characterization of efficient 
drugs and chemical probes.  
 
After a novel scaffold has been selected, the mechanism of action has to be 
elucidated before the natural product can be converted into successful drugs 
and research tools. This requires a full characterization of the biological 
activity of the compound, including identification of its targets and off-
targets. The recent advances in genomics, proteomics and metabolomics and 
the maturing of the chemical biology field in the past decade led to 
development of a variety of techniques that enable to do so. These 
techniques range from assays that enable determining the activity of natural 
products on specific proteins in a high-throughput manner (activity assays), 
to correlation of biological activities with known phenotypes, to protein 
profiling with chemical probes (ABPP and AfBP).5 Especially, the latter 
technique has become increasingly popular. Depending on the type of tag 
that has been incorporated into the probe molecule, protein profiling with 
chemical probes can be used to identify the targets and potential off-targets, 
to provide insight in the selectivity profile and to improve the 
understanding of the role of the target(s) in biologically relevant setting 
(Figure 2).6 
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Figure 2. Structure of activity-based probes inspired by natural products. An azide, an 
alkyne, a Bodipy and a biotin are here used as tags for visualisation and/or enrichment. 7-10 
1.2 Protein profiling to characterize the targets of natural 
products  
   
Direct and competitive protein profiling methodologies have been 
established to identify the targets of natural products. In the direct 
approach, the natural product serves as lead for the synthesis of a chemical 
probe that can be used to visualize and enrich the targets in an unbiased 
fashion. Incorporating a tag at a position that is not essential for the 
biological activity is often sufficient to obtain probe molecules of natural 
products containing a putative electrophilic trap (Figure 3A). The binding 
partners of the natural product become covalently modified upon reaction 
with the electrophile and the resulting protein-probe adducts can therefore 
be detected using for example a fluorescent tag (Figure 3C). Furthermore, 
when an affinity handle has been introduced, the tag also facilitates 
enrichment of the modified proteins by means of pull-down purification. 
Biotin has been commonly employed for this purpose, since the strong 
streptavidin-biotin interaction allows for efficient enrichment and stringent 
washing conditions to be used. Streptavidin pull-down thereby simplifies 
subsequent identification of the protein targets by mass spectrometry 




























































chemical probe. To overcome this issue, two-step approaches have been 
developed in which the tag is introduced onto the probe in a post-labeling 
step via a bio-orthogonal reaction, like the Staudinger ligation, copper 
catalyzed click chemistry and inverse electron-demand Diels-Alder 
reactions.11-13 The relatively small bio-orthogonal handles are less invasive 
and the probes therefore mimic the natural product more closely.   
 
Incorporating an affinity tag on natural products that lack a putative 
electrophile also enables enrichment of the interaction partners. However, 
this often results in a poor signal-to-noise ratio. Due to the transient nature 
of the interactions, weakly binding targets are lost during the washing steps 
and target identification therefore has met with less success. To improve the 
signal-to-noise ratio, the natural product can be equipped either with an 
electrophilic trap - a so-called warhead - that reacts with a nucleophilic 
amino acid in the proximity of the active site or with a photocrosslinker that 
gets activated upon radiation with light. The resulting probes will covalent 
modify their targets in a similar fashion as probes that exploit electrophiles 
present in natural products (Figure 3B). There are numerous examples that 
illustrate how converting natural products into probes has helped to 
pinpoint the targets and the mechanism by which the targets are inhibited 
(by mass-spectrometry identification of the modified residues). This method 
was applied to identify the protein targets of Vancomycin, a well-known 
non-covalent antibiotic.14 By incorporating benzophenone as a 
photocrosslinker and a small alkyne handle as a tag into the Vancomycin 
scaffold (Figure 4), Eirich et al. were able to confirm that the vancomycin 
photoprobe interact with the autolytic machinery by inhibiting Atl (a 
bifunctional autolysin) in E.faecalis. An ABC transporter protein was also 
labeled and identified. The inhibition of this transporter by Vancomycin 
probably reduces drastically the uptake of necessary nutrients for the 
bacteria. Applying this strategy on natural products that display 
antibacterial activity such as Vancomycin aids to the most important fight 
against bacterial resistance.      
6 
Figure 3. Design of a direct probe from an electrophilic (A) and a non-electrophilic natural 










1. Electrophiles found in nature
O
present within the natural scaffold provide selectivity by modifying nucleophilic residues










pull-down with streptavidin followed by


















choice of an electrophile usually 
based on the nucleophile to modify
provides a carbene or radical that allows









Some natural products already contain an electrophilic trap and are 
therefore readily available for protein profiling methodologies. Excellent 
examples that reflect this are the studies towards the antibacterial agents 
Showdomycin and Rugulactone by Sieber and coworkers. The group of 
Sieber realized that both compounds contain an α,β-unsaturated carbonyl 
motif that can function as a Michael acceptor and that these natural products 
therefore likely react with hyper-reactive amino acid residues, in particular 
cysteine. To identify the targets and to elucidate the mechanism of action of 
Showdomycin, they prepared a probe of this nucleoside antibiotic that was 
first isolated from Streptomyces showdoensis.15 Since the maleimide was 
considered to be essential for the activity, Sieber and coworkers 
incorporated an alkyne on the other side of the scaffold to avoid impairing 
the interaction with nucleophilic residues (Figure 4). The resulting probe 
displayed equal antibacterial activity against Staphylococcus aureus as the 
parent compound. Labeling experiments revealed that the probe binds 13 
different enzymes that are related to oxidative stress resistance in S. aureus, 
with the main hit being UDP-N-acetylglucosamine 1-carboxyvinyl 
transferase 1 (murA1). This enzyme catalyzes the first step of the cell wall 
biosynthesis in S. aureus and inhibition of this enzyme forms a likely 
explanation for the observed antibiotic activity. By profiling the targets of 
the Showdomycin probe in the methicillin-resistant S. aureus (MRSA) strain 
Mu50 and comparing the labeling profiles with nonresistant S. aureus 
strains, Sieber and coworkers demonstrated that murA2 was labeled in 
Mu50 strain but not in the nonresistant strains, while the expression levels 
for murA2 were similar in both strains. Such a tool is therefore also 
interesting to distinguish between closely related strains that display 
different pathogenicity and understand the mechanism of antibiotic 
resistance.  
The group of Sieber used a similar approach to identify the targets and 
elucidated the mechanism of action of Rugulactone,16 an antibacterial agent 
that was first isolated from Cryptocarya rugulosa.17 An alkyne was introduced 
to enrich proteins that react with α,β-unsaturated ketone in Rugulactone 
(Figure 4). Several targets were identified by the Rugulactone probe with 
mass spectrometry after pull-down experiment. MurA2 was one of the main 
hits and ThiD, a kinase involved in the biosynthesis of thiamine was for the 
first time inhibited by a small molecule. Culturing bacteria in thiamine-
deficient medium in the presence of Rugulactone led to more potent 




Figure 4. Structure of the probes based on Showdomycin, Rugulactone and Vancomycin. 
Highlighted in blue is the Micheal acceptor present in Rugulactone and Showdomycin 
and the benzophenone photocrosslinker incorporated in the Vancomycin scaffold. 
Highlighted in red is the alkyne tag.  
 
Converting natural products into chemical probes can clearly be used to 
further the biological understanding of natural products in general and it 
resulted in novel lead compounds and potential novel drug targets, but this 
strategy also has some disadvantages. The most important limitation of the 
direct protein profiling approach is that the introduction of a tag and a 
warhead has a great influence on the physical and biochemical properties. 
For example, these modifications can alter the hydrophobicity of the 
resulting probe and consequently the cell-permeability. As such, the tag and 
warhead may affect the biological activity and they thus determine the 
outcome of target identification studies. Varying the tag often leads to 
notable differences in the labeling profile of the probe. Even though the 
effect of tag can be minimized by employing two-step labeling strategies 
(vide supra), ideally the targets of the non-modified parent compound are 
identified. Competitive protein profiling with broad-spectrum probe 
molecules that react with one family or super-family of proteins allows this 
for natural products containing putative electrophilic traps. This method 
capitalizes on the fact that the electrophile in essence determines which 
hyper reactive amino acid residues are modified (usually a conserved 
nucleophilic residue in the active site), while the rest of the scaffold via non-
covalent interaction generates selectivity for one or another target within the 
class. By carefully selecting electrophiles that react with a specific amino 
acid residue and equipping these with a bio-orthogonal handle, broad-






















































have been obtained.18-22 Michael acceptors, epoxides, chloro- and 
iodoacetamides and sulfonate ester based probes have been developed to 
react predominantly with hyper reactive cysteine (Cys) residues.23 
Iodoacetamide alkyne (IAA) is mostly used as a proteomic platform to 
target Cys residues. Activated Ser residues, which are found in the active 
site of several enzyme families including the serine hydrolases (SHs), a 
superfamily of proteins that comprises 1% of the human proteome, have 
been profiled with carbamate, diphenyl phosphonate, β-lactam, β-lactone 
and fluorophosphonate (Fp) probes.23 Especially probes containing the latter 
type of electrophile have become popular tools to study SHs (Fp-rhodamine 
and Fp-biotin).18 Recently, broad-spectrum probes targeting nucleophilic 
lysine (Lys) residues have also been added to the profiling toolbox. An 
alkyne-functionalized N-hydroxysuccinimide-ester probe (NHS-ester) was 
developed by Ward et al.19 as a versatile reactivity-based probe. This small 
electrophile mainly labels Lys residues (around 50%) but also serines, 
threonines, and tyrosines in mouse liver proteomes. Furthermore, the group 
of Cravatt used a sulfotetrafluorophenyl (STP) based probe that showed a 
better selectivity towards Lys residues (> 80%) (Figure 5).  
 
Figure 5. Structure of broad-spectrum probes targeting Ser (A), Cys (B) and Lys (C) 
residues. 
 
The available Cys, Ser and Lys targeted probes provide a proteomic 
platform to screen inhibitors and identify the proteins that react with an 
electrophilic natural product by comparing the labeling profiling of these 
broad-spectrum probes in the presence and the absence of the natural 
product. Selecting the appropriate broad-spectrum probe is key in these 
profiling experiments. Hits within the serine hydrolase families will be 
missed, when a natural product is screened against a broad-spectrum 












































electrophilic traps can help to predicted which protein classes/residues will 
likely react with the putative electrophile within the natural product of 
interest and thus against which type of probe the product has to be screened 
(Figure 6). When a natural product is used as an inspiration to develop a 
specific activity-based probe, it is recommended to choose a tag that is 
different from the one used by the broad-spectrum probe to be able to 
screen them in a competitive experiment (Figure 6A and 6B, BODIPY and 
rhodamine can for example be screened simultaneously). The various 
profiles obtained from the competitive and direct activity based protein 
profiling can be compared in order to identify the targets of both the natural 
product and the newly developed natural product based probe 
simultaneously (Figure 6B). The main purpose of such studies is to be as 
thorough as possible to identify the protein targeted by a natural product. If 
the natural product screened interacts with proteins via non-covalent 
interactions or if the selected broad-spectrum probe is inadequate (or 
limited), the number of non-identified target proteins will be high and 
important hits might be overlooked.   
 
The advantages as well as the weaknesses of competitive profiling 
approaches over converting a natural product into a chemical probe are 
exemplified in a study by Abegg et al.21 They used a combination of direct 
profiling and two broad-spectrum hyper-reactive cysteine probes to 
characterize the targets of curcumin (Figure 7). To assure that the majority of 
the Cys residues could be labeled, they developed a novel alkylating agent 
based on benziodoxolone (EBX) that is complementary to the widely used 
iodoacetamide alkyne (IAA). Prior studies had shown that EBX selectively 
and rapidly modifies thiols in high-yield.24 Labeling of the resulting probe 
JW-RF-010 in HeLa cells was compared with the IAA. At pH 7.4 without 
additives at room temperature, both probes reacted with proteins. Using 10 
µM of probe, 2257 peptides were enriched by JW-RF-010 and 2184 by IAA. 
Among these peptides, 793 were unique to IAA and 866 unique to JW-RF-
010, which indicates that the two probes indeed address different subsets of 
hyper-reactive Cys residues and thus complement each other.  
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Figure 6. Broad-spectrum probes modifying cysteine, serine or lysine hyperreactive 
residues; direct and two-step natural product based probes (A); competitive activity-
based profiling can be used to identify the proteins targeted by a natural product by 
comparing the obtained profile with the adequate controls, a reprensentation of a gel is 
used to illustrate the competitive activity-based protein profiling assays (B); as an 
example, the protein indicated by number 1 in bold and italic targeted by the NP, the NP 
probe and the broad-spectrum probe is highlighted on the gel representation. 
Furthermore, JW-RF-010 revealed to be more specific probe towards Cys 
than IAA (97 versus 91.4%), which also targets to some extend Asp, Glu, Ser 
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complementarity of these Cys-specific probes. In a competitive experiment 
between curcumin and the Cys-specific probes, 57 proteins were identified 
while a direct curcumin-alkyne probe led to the identification of only 42 
targets. Among the identified proteins, 19 were specific to IAA and 16 to 
JW-RF-010. This unambiguously demonstrates that, besides labels of direct 
probes, also the choice of the broad-spectrum probe can affect the outcome 
of the experiment. Determining the targets both with competitive profiling 
and direct probes derived from the natural product of interest aids to define 
the real targets.  
 
  
Figure 7. Structures the broad-spectrum probes JW-RF-001 and IAA targeting Cys 
residues and of the curcumin probe.  
 
Even with these direct and competitive profiling methods, it is sometimes 
difficult to distinguish between hits that are related to the biological activity 
of natural products, the probe specific off-targets and non-specific 
background. Highly expressed proteins can impair the detection of less 
abundant protein targets by fluorescence in-gel scanning. To avoid this 
intrinsic bias of working at the protein level, mass spectrometry based-
techniques that enable quantification on a peptide level have been explored. 
Development of these quantitative proteomics approaches was assisted by 
the increased sensitivity and resolution of mass spectrometry equipment 
and the improvements in the analysis of large proteomic datasets. Using 
quantitative mass spectrometry approaches enabled the identification of 
targets that are overlooked by in-gel detection methods. The main 
quantitative techniques include SILAC (stable isotope labelling by amino 
acids in culture), iTRAQ (isobaric tag for relative and absolute quantitation), 
dimethyl labelling (DiMe), and label-free based methods (such as spectral 
counting) (these methods are critically compared in a review by Bantscheff 
et al.25). For the labeling approaches, the incorporation of isotopes into 
peptides is necessary. The mass spectrometer can distinguish between 
samples containing isotopes and non-treated samples to facilitate 
quantification. One example of this is the study towards the mode of action 
of hypothemycin in the parasite Trypanosoma brucei by Nishino et al.26 This 
polyketide natural product inhibits the growth of the parasite. In 

















of kinases, including MEK, ERK, PDGFR, VEGFR2, and FLT3. These kinases 
have in common that a cysteine residue precedes the catalytic DXG motif 
and Nishino et al. therefore hypothesized that CDXG kinases also were the 
targets in the T.brucei parasite. After synthesis of the hypothemycin alkyne 
probe (Figure 8), they first confirmed that its potency was similar to the 
natural product in parasite growth inhibition assays. The Michael acceptor 
present in hypothemycin indeed also reacted with CDXG kinases in T.brucei 
and TbGSK3 was identified as the main hit based on the abundance and 
protein coverage. Gel-free quantitative labeling experiments of four samples 
pre-treated by hypothemycin (0, 20, 200, or 1000 nM) and labeled with 
unique iTRAQ reagents at the peptide level revealed the extent of CDXG 
kinase labeling by the probe. From an analysis of the quantity of kinase 
recovery as a function of hypothemycin pretreatment (0, 20, 200, or 1000 
nM) it appeared that the kinase TbCLK1/2 rather than TbGSK3 was most 
sensitive to hypothemycin and silencing TbCLK1 by RNAi confirmed that 
TbCLK1 inhibition is important for parasite growth inhibition.   
  
 
Figure 8. Structure of hypothemycin and 4-hydroxy-2-nonenal based probes (A) and 
isotopically-tagged UV-cleavable reagent Az-UV-biotin (B).  
 
Studying the site of modification rather than the common protein based 
enrichment-identification sequence in combination with quantitative mass 
spectrometry techniques also provided insight in dynamics of modification 
of proteins with electrophiles in live cells. Yang et al.27 identified 
modification of peptides by the electrophilic lipid 4-hydroxy-2-nonenal 








































CuAAC reagent (“Az-UV-biotin”) (Figure 8). After incubation of HNE-
probe with RKO colon cancer cells, cell lysis and protein digestion; the Az-
UV-biotin is reacted with the peptides followed by enrichment-release by 
UV irradiation. This method then greatly facilitated the identification of 
modified peptides and their quantification. No less than 398 alkylation 
events were identified on intact cells.  They also exploited this approach to 
follow the dynamics of HNE in live cells and follow adduct turnover rates. 
The results obtained confirmed that the repair or reversion processes are 
only effective on intact cells (the same adducts were stable on lysates). The 
use of such quantitative platform is interesting as it provides a versatile 
method to follow cellular dynamics.  
 
1.3 Downstream applications of natural product derived 
chemical probes  
 
The use of natural product derived probes is not limited to target 
identification studies. These probes can also be employed to gain a deeper 
insight into the role of the targets in living cells. Probes equipped with 
fluorophores are particularly suitable for these studies, as they enable 
efficient and rapid in-gel detection of labeled proteins and fluorescent 
microscopy studies. 
 
The fluorescent probes that specifically and potently label one or a small 
sub-set of proteins can be used for live-cell imaging of the target proteins in 
their native environment. By virtue of fluorescence imaging microscopy 
insight can be obtained about the localization of the protein of interest under 
physiologically relevant conditions. This is elegantly illustrated for 
penicillin-binding proteins (PBPs) in bacteria. These enzymes are involved 
in the final steps in the synthesis of the peptidoglycan cell wall that 
surrounds most bacteria. The growing peptidoglycan chain is elongated by 
Class A high molecular weight (HMW) PBPs, which display 
glycosyltransferase activity. Furthermore, all PBPs catalyze crosslinking of 
the peptidoglycan and trimming of the stem-peptide. These latter activities 
are inhibited by natural product based antibiotics, such as penicillin or 
cephalosporin. The β-lactam motif within these antibiotics covalently 
modifies the active site serine residue required for the 
transpeptidase/carboxypeptidase activity. To study the role of PBPs, 
fluorescent derivatives of penicillin and cephalosporin have been 
prepared.10,28 In a recent comparative protein profiling experiment, 
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Kocaoglu et al. showed that the in vivo labeling pattern for Bocillin-FL and 
Cephalosporin C-F and C-T differ in Bacillus subtilis (Figure 9).28 While 
Bocillin-FL labels PBPs 1a/b, 2b, 2c, 3, 4 and 5, Ceph C-T only labels PBPs 
1a/b, 2b, 2c, and 4. The authors exploited these differences to study the 
localization of PBP3 and PBP5 with fluorescence imaging. By treating live B. 
subtilis cells first with Ceph C-T and subsequently with Bocillin-FL, they 
revealed that both probes were not co-localized within the same region of a 
cell, which suggests that PBP3 and PBP5 may have specific function during 
cell division. Similar results were obtained for Streptococcus pneumonia. Also 
in this cell line Ceph C-T labeled a different subset of PBPs than Bocillin-FL 
(PBPs 1b and 3 for Ceph C-T and PBPs 1a/b, 2x/a/b and 3 for Bocillin-FL). 
Super-resolution images were then captured after dual labeling and only 
little co-localization was observed indicating again an evident difference in 
distribution.  As such profiling of the PBPs with probes for the first time 
showed that the endogenously expressed active PBPs localize to different 
sites within the cell and that these PBPs may have different functions in the 
synthesis and homeostasis of peptidoglycan.  
 
Figure 9. Cephalosporin and Penicillin based probes (A) and schematic representation of 
the gel and the microscopy picture on B.subtilis demonstrating the absence of co-
localization indicating that the PBPs targeted by the probes are found in different areas of 























































Furthermore, specific natural product-derived probes in combination with 
broad-spectrum ABPs have helped to screen in an almost high-througput 
manner (focused) compound libraries for enzyme specific inhibitors. 
Competition experiments with the broad-spectrum probe give a good 
indication for the selectivity of a compound within an enzyme family, as 
was shown for the fluorophosphonates probes Fp-rhodamine and Fp-biotin. 
The large serine hydrolase enzyme family consists of more than 200 
enzymes in humans and the enzymes are involved in the cleavage of ester, 
amide or thioester bonds in a wide range of pathways.29 By screening 
carbamates versus Fp-rhodamine and Fp-biotin,30-34 the selectivity of 
carbamate containing inhibitors could be determined and these leads were 
successfully developed further into a handful of carbamate based ABPs. 
However some enzymes within the serine hydrolase family do not react 
with Fp-rhodamine and Fp-biotin, such as diacyl glycerol lipase-α (DAGL-
α), or are less abundant. Screening for inhibitors of these proteins can be 
achieved by using a combination of specific and broad-spectrum probes, as 
demonstrated by Baggelaar et al.35 To develop novel reversible inhibitors of 
DAGL-α, the authors used the drug tetrahydrolipstatin (THL), which is 
derived from the natural product lipstatin, as a starting point. This natural 
product derivative covalently inhibits DAGL-α and introduction of a 
BODIPY-dye on THL yielded the probe MB064 (Figure 10), which reacts 
with tubulin, glyceraldehyde-3-phosphate dehydrogenase, ABHD16 and 
DAGL-α in mouse brain membrane proteome. The labeling profile of MB064 
is much more specific than Fp-rhodamine in the same biological settings. 
Competitive activity based protein-profiling assays with MB064 facilitates 
sensitive detection of DAGL-α inhibition, while Fp-rhodamine enabled 
determining the general selectivity of the compound within the SH family. 
These screen campaigns resulted in the identification of specific inhibitors 
for FAAH and DAGL-α and demonstrate the effectiveness of screening 
simultaneously against selective and broad-spectrum probes.   
                                                                                      17    2 
Figure 10. MB064 (A) and schematic outcome of the competitive activity-based profiling 
of THL versus Fp-rho or MB064 (B).  
 
1.4 Conclusion  
 
In conclusion, chemical probes are completing the traditional methods -such 
as biochemical and genetic modifications- to gain insight in the connections 
between proteins, their specificities for substrates and their importance in 
diseases. Natural products are a great inspiration for the development of 
probes that can be employed to characterize the targets of the natural 
product and to study the function of the protein by using the probe in 
downstream application.   
 
Several interesting guidelines emerge from the selected examples. Firstly, 
for the development of novel probe molecules, it is essential to recognize 
interesting and original natural products both containing and not containing 
electrophilic traps. These scaffolds should be accessible in an effective way 
to allow modification of the original scaffold with the necessary tags and/or 
reactive group. For the target identification it is essential to combine broad-
spectrum and natural product derived probes. It is also preferable to 
identify the targets using quantitative methods to assure the relevance of the 
hit and overcome the limitation of gel-based assays. Thirdly, the field of 
ABPP encloses a plethora of techniques such as fluorescence microscopy 
that should be implemented to gain insight into biological processes or 
diseases. Finally, it is necessary to develop and characterize new broad-
spectrum ABPs and to carefully take advantage of the ones already available 
to screen scaffolds and obtain specific and potent inhibitors and ABPs.  
 
Inspired by nature (or not), it is safe to believe that chemical probes can be 
designed for almost any protein of interest containing a nucleophilic residue 





















These probes will help comprehending nature by pursuing the goal to 
understand every single protein function.2   
 
1.5 Brabantamide as an inspiration and outline of the 
thesis   
 
The research in this thesis focused at employing the above described 
methodologies to characterize the targets of the enol cyclocarbamate 
scaffold found in brabantamides. These lipopeptides have been reported to 
have variety of interesting bioactivities. Brabantamide A has antibacterial, 
antifungal, antioomycete activity and inhibits the mammalian 
phospholipase A2 (Lp-PLA2) (a SH).36-42  
 
Also from a structural point of view, Brabantamides are interesting. These 
lipopeptides consist of a rhamnosylated beta-hydroxy fatty acid that is 
attached via an imide to a rare 5,5 (brabantamide A, B and C) or a 5,7-fused 
bicyclic enol carbamate ring system (SB-31502) (Figure 11).36 
Simplified(semi-) synthetic analogues that lack the rhamnose, as in 
deglycosylated brabantamide A,42 and the imide, as in the derivative 
synthesized by Pinto et al.39 (Figure 12) maintained activity towards Lp-
PLA2. Even changing the stereochemistry from R to S ring or the chain 
length did not greatly affect activity, which suggested that the bicyclic enol 
carbamate ring system is at the origin of the observed activity.  
 
 
Figure 11. Brabantamides A,B and C natural products first isolated from Pseudomonas 
















































The two putative electrophilic traps within the scaffold, the activated 
carbamate and the Michael acceptor, advert potential covalent interaction 
with Ser and Cys residues. Mass spectrometry by Thirklette et al. confirmed 
that phospholipase-brabantamide A adducts are formed.40    
 
Figure 12. Brabantamide A bears two putative electrophiles potentially reacting with Ser, 
Cys or Thr ; several approaches can be envisioned to identify the targets of the 
synthesized enol carbamates.  
 
Based on this, we decided to study the mechanism of action of this natural 
product scaffold using chemical proteomics. In this thesis, a series of probe 
molecules based on the Brabantamide A scaffold is developed. A set of 
inhibitors, two-steps probes and direct probes were synthesized and 
biological activity was characterized. The aim of the thesis is to explain the 
observed phenotype in bacteria by identifying the molecular targets using 
the competitive and direct profiling approaches, to gain insight into proteins 
that react with enol-cyclocarbamate in mammalian cells and to improve the 
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improved probes and inhibitors. Chapter 2 describes the design and 
synthesis of a panel of derivatives as well as their activity versus Bacillus 
subtilis 168 and Streptococcus pneumoniae. We used a combination of 
fluorescence microscopy and competitive ABPP to study the mechanism 
action and we identified penicillin-binding proteins as one of the targets of 
these compounds. In Chapter 3, the reactivity of four enol cyclocarbamate 
probes (2 two-steps probes and 2 fluorescent probes) is studied in the 
mammalian A549 cells. Chemoproteomics studies identified ALDH3A1 and 
RALDH1 and labeling experiments on recombinantly expressed confirmed 
that the novel probes label the important cancer markers RALDH1 and 
ALDH3A1. Chapter 4 describes the use of Fp-rhodamine and Fp-biotin to 
study the reactivity of the panel of compounds towards serine hydrolases 
first on recombinant Lp-PLA2 and esterase from Bacillus subtilis and then on 
both bacteria and mammalian cells (respectively Bacillus subtilis and A549). 
In Chapter 5, we studied the reactivity of a model enol carbamate to gain 
insight in how different nucleophiles react with the scaffold. We used this 
insight to tune the electrophilicity of both the carbamate and the Michael 
acceptor present in the brabantamide scaffold by synthesizing vinyl sulfone, 
vinyl ester and monocyclic derivatives. In Chapter 6, the research is 
summarized and future directions towards the applications of enol 
carbamate electrophiles as well as improvement of the probes are discussed.
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